Cargando…
The effects of apremilast on the QTc interval in healthy male volunteers: a formal, thorough QT study
Objective: This study was conducted to evaluate the effect of apremilast and its major metabolites on the placebo-corrected change-from-baseline QTc interval of an electrocardiogram (ECG). Materials and methods: Healthy male subjects received each of 4 treatments in a randomized, crossover manner. I...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dustri-Verlag Dr. Karl Feistle
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4949396/ https://www.ncbi.nlm.nih.gov/pubmed/27285466 http://dx.doi.org/10.5414/CP202555 |
_version_ | 1782443421082845184 |
---|---|
author | Palmisano, Maria Wu, Anfan Assaf, Mahmoud Liu, Liangang Park, C. Hyung Savant, Ishani Liu, Yong Zhou, Simon |
author_facet | Palmisano, Maria Wu, Anfan Assaf, Mahmoud Liu, Liangang Park, C. Hyung Savant, Ishani Liu, Yong Zhou, Simon |
author_sort | Palmisano, Maria |
collection | PubMed |
description | Objective: This study was conducted to evaluate the effect of apremilast and its major metabolites on the placebo-corrected change-from-baseline QTc interval of an electrocardiogram (ECG). Materials and methods: Healthy male subjects received each of 4 treatments in a randomized, crossover manner. In the 2 active treatment periods, apremilast 30 mg (therapeutic exposure) or 50 mg (supratherapeutic exposure) was administered twice daily for 9 doses. A placebo control was used to ensure double-blind treatment of apremilast, and an open-label, single dose of moxifloxacin 400 mg was administered as a positive control. ECGs were measured using 24-hour digital Holter monitoring. Results: The two-sided 98% confidence intervals (CIs) for ΔΔQTcI of moxifloxacin completely exceeded 5 ms 2 – 4 hours postdose. For both apremilast dose studies, the least-squares mean ΔΔQTcI was < 1 ms at all time points, and the upper limit of two-sided 90% CIs was < 10 ms. There were no QT/QTc values > 480 ms or a change from baseline > 60 ms. Exploratory evaluation of pharmacokinetic/pharmacodynamic data showed no trend between the changes in QT/QTc interval and the concentration of apremilast or its major metabolites M12 and M14. Conclusions: Apremilast did not prolong the QT interval and appears to be safe and well tolerated up to doses of 50 mg twice daily. |
format | Online Article Text |
id | pubmed-4949396 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Dustri-Verlag Dr. Karl Feistle |
record_format | MEDLINE/PubMed |
spelling | pubmed-49493962016-08-03 The effects of apremilast on the QTc interval in healthy male volunteers: a formal, thorough QT study Palmisano, Maria Wu, Anfan Assaf, Mahmoud Liu, Liangang Park, C. Hyung Savant, Ishani Liu, Yong Zhou, Simon Int J Clin Pharmacol Ther Research Article Objective: This study was conducted to evaluate the effect of apremilast and its major metabolites on the placebo-corrected change-from-baseline QTc interval of an electrocardiogram (ECG). Materials and methods: Healthy male subjects received each of 4 treatments in a randomized, crossover manner. In the 2 active treatment periods, apremilast 30 mg (therapeutic exposure) or 50 mg (supratherapeutic exposure) was administered twice daily for 9 doses. A placebo control was used to ensure double-blind treatment of apremilast, and an open-label, single dose of moxifloxacin 400 mg was administered as a positive control. ECGs were measured using 24-hour digital Holter monitoring. Results: The two-sided 98% confidence intervals (CIs) for ΔΔQTcI of moxifloxacin completely exceeded 5 ms 2 – 4 hours postdose. For both apremilast dose studies, the least-squares mean ΔΔQTcI was < 1 ms at all time points, and the upper limit of two-sided 90% CIs was < 10 ms. There were no QT/QTc values > 480 ms or a change from baseline > 60 ms. Exploratory evaluation of pharmacokinetic/pharmacodynamic data showed no trend between the changes in QT/QTc interval and the concentration of apremilast or its major metabolites M12 and M14. Conclusions: Apremilast did not prolong the QT interval and appears to be safe and well tolerated up to doses of 50 mg twice daily. Dustri-Verlag Dr. Karl Feistle 2016-08 2016-06-10 /pmc/articles/PMC4949396/ /pubmed/27285466 http://dx.doi.org/10.5414/CP202555 Text en © Dustri-Verlag Dr. K. Feistle http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Palmisano, Maria Wu, Anfan Assaf, Mahmoud Liu, Liangang Park, C. Hyung Savant, Ishani Liu, Yong Zhou, Simon The effects of apremilast on the QTc interval in healthy male volunteers: a formal, thorough QT study |
title | The effects of apremilast on the QTc interval in healthy male volunteers: a formal, thorough QT study |
title_full | The effects of apremilast on the QTc interval in healthy male volunteers: a formal, thorough QT study |
title_fullStr | The effects of apremilast on the QTc interval in healthy male volunteers: a formal, thorough QT study |
title_full_unstemmed | The effects of apremilast on the QTc interval in healthy male volunteers: a formal, thorough QT study |
title_short | The effects of apremilast on the QTc interval in healthy male volunteers: a formal, thorough QT study |
title_sort | effects of apremilast on the qtc interval in healthy male volunteers: a formal, thorough qt study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4949396/ https://www.ncbi.nlm.nih.gov/pubmed/27285466 http://dx.doi.org/10.5414/CP202555 |
work_keys_str_mv | AT palmisanomaria theeffectsofapremilastontheqtcintervalinhealthymalevolunteersaformalthoroughqtstudy AT wuanfan theeffectsofapremilastontheqtcintervalinhealthymalevolunteersaformalthoroughqtstudy AT assafmahmoud theeffectsofapremilastontheqtcintervalinhealthymalevolunteersaformalthoroughqtstudy AT liuliangang theeffectsofapremilastontheqtcintervalinhealthymalevolunteersaformalthoroughqtstudy AT parkchyung theeffectsofapremilastontheqtcintervalinhealthymalevolunteersaformalthoroughqtstudy AT savantishani theeffectsofapremilastontheqtcintervalinhealthymalevolunteersaformalthoroughqtstudy AT liuyong theeffectsofapremilastontheqtcintervalinhealthymalevolunteersaformalthoroughqtstudy AT zhousimon theeffectsofapremilastontheqtcintervalinhealthymalevolunteersaformalthoroughqtstudy AT palmisanomaria effectsofapremilastontheqtcintervalinhealthymalevolunteersaformalthoroughqtstudy AT wuanfan effectsofapremilastontheqtcintervalinhealthymalevolunteersaformalthoroughqtstudy AT assafmahmoud effectsofapremilastontheqtcintervalinhealthymalevolunteersaformalthoroughqtstudy AT liuliangang effectsofapremilastontheqtcintervalinhealthymalevolunteersaformalthoroughqtstudy AT parkchyung effectsofapremilastontheqtcintervalinhealthymalevolunteersaformalthoroughqtstudy AT savantishani effectsofapremilastontheqtcintervalinhealthymalevolunteersaformalthoroughqtstudy AT liuyong effectsofapremilastontheqtcintervalinhealthymalevolunteersaformalthoroughqtstudy AT zhousimon effectsofapremilastontheqtcintervalinhealthymalevolunteersaformalthoroughqtstudy |